Catalina Research Institute, LLC Introducing the COMP 006 clinical study
Many people who receive antidepressant treatment for their depression do not get an adequate response to the medicines they are taking. If someone is taking two or more antidepressants and they are failing, this is sometimes referred to as treatment-resistant depression or TRD.
The COMP 006 study is looking into a new treatment approach for people with TRD using an investigational medicine given with psychological support. The study is suitable for people who have been diagnosed with major depression and are currently experiencing a recurrent or single episode of depression but that have not responded to antidepressant treatment.
You may be eligible to participate in a Compass Pathfinder study if you:
Are 18 years of age or older
Have been diagnosed with major depression (single or recurrent episodes)
Are experiencing treatment-resistant depression, defined as failing 2, 3 or 4 pharmacological treatments for your current episode of depression
Meet additional study criteria.
COMP006 is a three-part study which will last up to 62 weeks. Compensation $100 per completed visit.
Per appointment only.
Call to schedule (909) 590-8409.
Business hours Monday- Friday 7am-4pm
Follow us on Instagram to see what studies we have enrolling. @catalinaresearchllc
Catalina Research Institute
9525 Monte Vista Ave, Suite 200
Montclair, CA 91763
909-590-8409